United Therapeutics (UTHR) had its price target raised by UBS Group AG from $655.00 to $705.00. They now have a "buy" rating on the stock.
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference [Yahoo! Finance]
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference
United Therapeutics (UTHR) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
United Therapeutics Corporation (UTHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]